Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
6.91
-0.09 (-1.29%)
At close: May 21, 2025, 4:00 PM
6.90
-0.01 (-0.14%)
After-hours: May 21, 2025, 4:04 PM EDT
Atara Biotherapeutics Employees
Atara Biotherapeutics had 153 employees as of December 31, 2024. The number of employees decreased by 72 or -32.00% compared to the previous year.
Employees
153
Change (1Y)
-72
Growth (1Y)
-32.00%
Revenue / Employee
$1,305,438
Profits / Employee
-$102,229
Market Cap
40.49M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ATRA News
- 4 days ago - Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors - Business Wire
- 6 days ago - Atara Biotherapeutics Announces First Quarter Financial Results and Operational Progress - Business Wire
- 6 days ago - Atara Biotherapeutics Announces Pricing of $16 Million Offering - Business Wire
- 15 days ago - Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel) - Business Wire
- 2 months ago - Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress - Business Wire
- 2 months ago - The Schall Law Firm Invites Investors With Losses In Atara Biotherapeutics, Inc. To Join A Securities Fraud Investigation - Accesswire
- 3 months ago - The Schall Law Firm Invites Shareholders With Losses In Atara Biotherapeutics, Inc. To Join A Securities Fraud Investigation - Accesswire
- 3 months ago - Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities laws - PRNewsWire